Examples
| Generic Name | Brand Name |
|---|
| adalimumab | Humira |
Adalimumab is given as a shot under the skin (subcutaneous
injection).
How It Works
Adalimumab reduces the effects of tumor
necrosis factor (TNF). TNF is produced in your body in times of
inflammation and attaches to the joint surface,
causing damage to soft tissues, cartilage, and bones. Adalimumab is a
disease-modifying antirheumatic drug (DMARD), which means it slows the
progression of
rheumatoid arthritis. DMARDs are also called
immunosuppressive drugs or slow-acting antirheumatic drugs (SAARDs).
Why It Is Used
Adalimumab has been approved for use
in treating adults with moderate to severe rheumatoid arthritis. Adalimumab may
be used alone or in combination with other DMARDs such as methotrexate.1
How Well It Works
Adalimumab appears to work rapidly
and is well-tolerated. A clinical trial of adalimumab used in combination with
methotrexate found a 20% improvement in 67% of people who were given the
medication, with improvements noticeable after 1 week of treatment.2 In another study of adalimumab used alone, researchers report
significant, rapid, sustained reductions in disease activity and improved
physical function, including reduced swelling and pain.3
Side Effects
The most common side effect of TNF
antagonists, such as adalimumab, is an allergic reaction to the injection
(shot). If you have a reaction to the shot, it will happen right away, either
during the shot or within 1 to 2 hours after the shot. Your doctor may give you
medicines to prevent or stop the reaction.
Symptoms of a reaction
to the shot include:
- Fever.
- Chills.
- Chest
pain.
- Shortness of breath.
- Itching
(pruritus).
- Headache.
- Nausea.
- Heat and
redness (flushing) in the
face.
- Rash.
- Fatigue.
- Dizziness.
Warnings about serious side effects of TNF antagonists have
been issued. The U.S. Food and Drug Administration (FDA) and the drug’s
manufacturers have warned about:
- An increased risk of a serious infection (such
as
tuberculosis). If you have had tuberculosis (TB) or
know someone who has had it, tell your doctor. TNF antagonists also affect your
body's ability to fight all infections. So if you get a fever, cold, or the flu
while you are taking this medicine, let your doctor know right
away.
- An increased risk of blood or nervous system disorders. Call
your doctor if you have symptoms of blood disorders (such as bruising or
bleeding) or symptoms of nervous system problems (such as numbness, weakness,
tingling, or vision problems).
- A possible increased risk of
lymphoma (a type of blood cancer). It is not clear
whether this increase is because of the drug or because people with this
disease may already have a higher risk. There have been reports of a rare kind
of lymphoma, occurring mostly in children and teens taking TNF antagonists,
that often results in death.
- An increased risk of liver injuries.
Call your doctor if your skin starts to look yellow, if you are very tired, or
if you have a fever or dark brown urine.
See Drug Reference for a full list of side effects. (Drug
Reference is not available in all systems.)
What To Think About
Adalimumab is a new TNF inhibitor,
approved by the U.S. Food and Drug Administration. Like etanercept and
infliximab, adalimumab is significantly more expensive than DMARDs such as
methotrexate and sulfasalazine.1
Adalimumab should not be used by pregnant women or women of childbearing
age who are not using reliable birth control. If you are going to take
adalimumab, you should be on some form of reliable birth control. If you plan
to become pregnant, check with your health professional before stopping birth
control and trying to become pregnant.
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.